🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07204795
Recruiting Not applicable

Effect of Preoperative Oral Carbohydrate Drink on ObsQoR-10 Score After Elective Cesarean Under Neuraxial Anesthesia

NCT07204795 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-05-20
Last updated
2025-10-02

Condition(s) studied

ObsQor-10Cesarean SectionPreoperative Fasting

Investigational drug(s) / intervention(s)

Distilled water groupCarbohydrate Drink

Distilled water group: Group A participants will receive 400 mL of distilled water orally, two hours before surgery.

Carbohydrate Drink: Group A participants will receive 400 mL of a commercially available clear carbohydrate-rich drink orally, two hours before surgery.

Study summary

The goal of this clinical trial is to determine whether a preoperative oral carbohydrate-rich clear drink can improve recovery in women undergoing elective cesarean section under neuraxial anesthesia. The main outcomes it aims to answer are:

Primary Outcome: Does the carbohydrate drink improve ObsQoR-10 scores at 24 and 48 hours postoperatively?

Secondary Outcomes: Does it reduce patients' hunger, thirst, and anxiety levels?

Researchers will compare patients receiving a 400 ml oral carbohydrate-rich clear drink 2 hours before surgery (Group A) to those receiving 400 ml distilled water (Group B), to assess differences in recovery and comfort.

Participants will:

Be randomized into two equal groups (n=50 each) using a computer-generated randomization table

Receive standardized anesthesia and postoperative analgesia

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: Age ≥18 years Scheduled for elective cesarean section under neuraxial anesthesia Gestational age ≥37 weeks Exclusion Criteria: Contraindication to neuraxial anesthesia Age \<18 years Refusal to participate in the study Obesity Hiatal hernia Intestinal obstruction Gastroesophageal reflux disease (GERD) Diabetes mellitus Fetal anomalies Eclampsia or preeclampsia Substance abuse Chronic pain conditions

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ataturk University Research Hospital Erzurum Turkey (Türkiye) Recruiting

More Ataturk University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07204795 on ClinicalTrials.gov ↗ ← All trials in Turkey